Work

Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results

Year: 2005

Type: article

Study design: Observational Study

Source: Melanoma Research

DOI: 10.1097/00008390-200512000-00007

Authors: Julia Valencak, Elisabeth Heere-Ress, Tatjana Traub-Weidinger, Markus Raderer, Achim Schneeberger, Theresia Thalhammer, Sylvia Aust, Gerhard Hamilton, Irene Virgolini, Hubert Pehamberger

Institutions: Medical University of Vienna, Innsbruck Medical University, Universität Innsbruck

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2064616786

FWCI: 0.215

Cites: 35

Cited by: 12

Related to: 10